Biological Research Laboratories, Nissan Chemical Corporation, Saitama, Japan.
Faculty of Health Sciences, University of Bristol, UK.
FEBS J. 2021 Oct;288(19):5650-5667. doi: 10.1111/febs.15867. Epub 2021 May 2.
Three-dimensional (3D) cultures of cancer cells in liquid without extracellular matrix (ECM) offer in vitro models for metastasising conditions such as those in vessels and effusion. However, liquid culturing is often hindered by cell adhesiveness, which causes large cell clumps. We previously described a liquid culture material, LA717, which prevents nonclonal cell adhesion and subsequent clumping, thus allowing clonal growth of spheroids in an anchorage-independent manner. Here, we examined such liquid culture cancer spheroids for the acquisition of apical-basal polarity, sensitivity to an Akt inhibitor (anticancer drug MK-2206) and interaction with ECM. The spheroids present apical plasma membrane on the surface, which originated from the failure of polarisation at the single-cell stage and subsequent defects in phosphorylated ezrin accumulation at the cell boundary during the first cleavage, failing internal lumen formation. At the multicellular stage, liquid culture spheroids presented bleb-like protrusion on the surface, which was enhanced by the activation of the PI3K/Akt pathway and reduced by PI3K/Akt inhibitors. Liquid culture spheroids exhibited slow proliferation speed and low endogenous pAkt levels compared with gel-cultured spheroids and 2D-cultured cells, explaining the susceptibility to the Akt-inhibiting anticancer drug. Subcutaneous xenografting and in vitro analysis demonstrated low viability and adhesive property of liquid culture spheroids to ECM, while migratory and invasive capacities were comparable with gel-cultured spheroids. These features agree with the low efficacy of circulating tumour spheroids in the settling step of metastasis. This study demonstrates the feature of anchorage-independent spheroids and validates liquid cultures as a useful method in cancer spheroid research.
三维(3D)无细胞外基质(ECM)的癌细胞液体培养为转移条件提供了体外模型,例如在血管和渗出液中。然而,液体培养通常受到细胞黏附性的阻碍,这会导致细胞聚集成大团块。我们之前描述了一种液体培养材料 LA717,它可以防止非克隆细胞黏附和随后的聚集,从而允许克隆球状体以无锚定的方式生长。在这里,我们研究了这种液体培养的癌症球体,以获取顶端-基底极性、对 Akt 抑制剂(抗癌药物 MK-2206)的敏感性以及与 ECM 的相互作用。球体表面存在顶端质膜,这是由于在单细胞阶段极化失败以及随后在第一次分裂过程中细胞边界处磷酸化 ezrin 积累缺陷导致内部腔形成失败所致。在多细胞阶段,液体培养球体表面呈现出泡状突起,这是由 PI3K/Akt 途径的激活增强的,而 PI3K/Akt 抑制剂则降低了这种突起。与凝胶培养球体和 2D 培养细胞相比,液体培养球体的增殖速度较慢,内源性 pAkt 水平较低,这解释了它们对 Akt 抑制抗癌药物的敏感性。皮下异种移植和体外分析表明,液体培养球体对 ECM 的活力和黏附性较低,而迁移和侵袭能力与凝胶培养球体相当。这些特征与循环肿瘤球体在转移的定居步骤中的低疗效一致。本研究展示了无锚定球体的特征,并验证了液体培养作为癌症球体研究的一种有用方法。